Navigation Links
Hospira Highlights Progress in 2010 at Its 2011 Annual Meeting of Shareholders
Date:5/10/2011

LAKE FOREST, Ill., May 10, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today held its 2011 Annual Meeting of Shareholders in Washington, D.C. The agenda included votes on seven items as well as an update on the company's progress in 2010 and its position going forward.

"2010 was a year marked with milestone achievements, but also scattered challenges," said F. Michael Ball, chief executive officer. "Through a keen focus on staying the course, we transformed obstacles into opportunities. In 2011, we continue to deliver on our strategy, remaining focused on propelling Hospira towards a future of sustainable top-ranking performance and increased value for our shareholders."

During the annual meeting, shareholders:

  • elected the following directors: Irving W. Bailey, II; F. Michael Ball; and Jacque J. Sokolov, M.D.; all Class I directors whose terms expire in 2014;
  • approved three amendments to Hospira's restated certificate of incorporation;
  • approved, by means of a shareholder advisory vote, the compensation of Hospira's named executive officers ("say on pay") as disclosed in the 2011 proxy statement;
  • determined, by means of a shareholder advisory vote, that the "say-on-pay" vote will occur every year; and
  • ratified the appointment of Deloitte & Touche LLP as Hospira's auditors for 2011.

A full description of the above matters is included in Hospira's proxy statement related to the meeting. The proxy statement is available on Hospira's website at www.hospirainvestor.com, as are Mr. Ball's remarks.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has approximately 14,000 employees. Learn more at www.hospira.com.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hospira Reports First-Quarter 2011 Results
2. Hospira Board Authorizes $1 Billion Share Repurchase Program
3. Hospira to Present at Bank of America / Merrill Lynch 2011 Health Care Conference May 11, 2011
4. Hospira Reinforces Importance of Clinical Surveillance Technology in Line With World Health Day Focus on Antimicrobial Resistance
5. Hospira to Host Conference Call for First-Quarter 2011 Results
6. Hospira Submits 510(k) Application to FDA for Symbiq™ Infusion System Modifications
7. Hospira Launches Enhanced TheraDoc™ Clinical Surveillance System to Support Patient Safety and Help Improve Care
8. Hologic, Hospira, Boston Scientific, Allergan to Participate in Leading Medical Device Manufacturing Symposium
9. Hospira Announces U.S. Approval of Generic Docetaxel
10. Hospira Board Names F. Michael Ball New CEO; Christopher B. Begley to Assume Executive Chairman Role
11. Hospira MedNet™ Portal Safety Software Benchmarking System Debuts at HIMSS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2017)... May 4, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... big data solutions, today announced that it is teaming ... STI Technologies Limited to lower diabetes healthcare costs in ... innoviCares card, which is available throughout all provinces and ... will be eligible for additional savings when shopping for ...
(Date:5/4/2017)... , May 4, 2017   BioLife Solutions ... developer, manufacturer and marketer of proprietary clinical grade ... ("BioLife" or the "Company"), today announced that the Company,s ... market close on Thursday, May 11, 2017, and that ... webcast at 1:30 p.m. PT that afternoon. Management will ...
(Date:5/3/2017)...  Kalorama Information notes that transplant diagnostics is ... and this is projected to continue to 2021. ... or bone marrow transplants require histocompatibility between the ... this task. This according to a new report ... various PCR-based methodologies, Sanger sequencing and NGS used ...
Breaking Medicine Technology:
(Date:5/24/2017)... ... 24, 2017 , ... Patients who want to receive cosmetic dentistry procedures such ... Joseph Bedich for a consultation, with or without a referral. Dr. Bedich enjoys improving ... , Dr. Bedich offers a variety of cosmetic dentistry services at his ...
(Date:5/24/2017)... ... May 24, 2017 , ... Medic CE , a ... Truth about Pediatric Septic Shock” hosted by the Journal of Emergency Medical Services (JEMS). ... Eastern time, will be presented by Captain Rommie Duckworth, LP, a career fire captain ...
(Date:5/24/2017)... ... May 24, 2017 , ... ... and nonprofit hospitals and health systems in the nation and help their organizations ... led professional organizations and been instrumental in developing successful hospital and health system ...
(Date:5/23/2017)... SANTA CLARA, CA (PRWEB) , ... May 23, 2017 , ... ... government and financial organizations, today announced CIO Applications magazine has named the company a ... of its innovative use of the Cloud to help organizations simply and proactively address ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... a 2017 Best in KLAS category winner, has named Daniel P. Bullington as ... and enhance its technology platform and product offerings,” says Justin Neece, president. “Daniel ...
Breaking Medicine News(10 mins):